
Dr. Ruth Fernandez Ruiz joined HSS in 2022 as an Assistant Attending Physician and Assistant Professor of Medicine at Weill Cornell Medicine. She received her medical degree from the Universidad Central de Venezuela, graduating top of her class (Magna Cum Laude) on a research track. She then practiced general medicine in rural and urban areas in Venezuela,followed by completion of a two-year internal medicine residency program at the Hospital de Clínicas Caracas, where she served as chief resident during her last year of training. Dr. Fernandez Ruiz also trained in internal medicine at the University of Iowa, after which she did her rheumatology training and chief fellow year at New York ...
Enpatoran, a first-in-class, selective, orally administered toll-like receptor 7/8 inhibitor, in systemic and cutaneous lupus erythematosus: results from a randomised, placebo-controlled phase Ib study.
Erratum to "2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective" [The Journal of Arthroplasty 38 (2023) 2193-2201].
Advances in the management of systemic lupus erythematosus.